TGFβ1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells

A. Tótth, A. Sebestyén, G. Barna, K. Nagy, A. Göndör, J. Bocsi, R. Mihalik, I. Peták, J. Houghton, L. Kópper

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Transforming growth factor beta 1 (TGFβ1) is an antiproliferative and proapoptotic cytokine for normal B-cells, however many B-cell lymphomas have lost their response to TGFβ1. The aim of this study was to identify the sequence of events in apoptosis induced by TGFβ1 in an EBV negative, human B-cell lymphoma line (HT58). The proportion of apoptotic cells increased gradually (up to 72 hr) at an optimal dose range of 0.5-1.0 ng/ml. The induced cell death required the action of downstream caspases. Caspase activation was accompanied by an increase in the permeability of mitochondrial membranes, but there was no change in the expression of certain members of Bcl-2 family (Bcl-2, Bax, Bcl-XL). Similarly, none of the death receptors or ligands were involved in apoptosis induction. Further study will include the participation of TGFβ1 target genes in the pore formation of mitochondrial membranes and/or the elimination ora putative survival signal.

Original languageEnglish
Pages (from-to)1207-1212
Number of pages6
JournalAnticancer Research
Volume21
Issue number2 A
Publication statusPublished - 2001

Fingerprint

Caspase 1
Death Domain Receptors
Transforming Growth Factor beta
Lymphocytes
Apoptosis
Mitochondrial Membranes
B-Cell Lymphoma
Caspases
Human Herpesvirus 4
Permeability
B-Lymphocytes
Cell Death
Cytokines
Ligands
Cell Line
Survival
Genes

Keywords

  • Apoptosis
  • Caspases
  • Death receptors
  • Lymphoma
  • Mitochondria
  • TGFβ1

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

TGFβ1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells. / Tótth, A.; Sebestyén, A.; Barna, G.; Nagy, K.; Göndör, A.; Bocsi, J.; Mihalik, R.; Peták, I.; Houghton, J.; Kópper, L.

In: Anticancer Research, Vol. 21, No. 2 A, 2001, p. 1207-1212.

Research output: Contribution to journalArticle

@article{bc2f0cd15a464c628dcad7775a0c9847,
title = "TGFβ1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells",
abstract = "Transforming growth factor beta 1 (TGFβ1) is an antiproliferative and proapoptotic cytokine for normal B-cells, however many B-cell lymphomas have lost their response to TGFβ1. The aim of this study was to identify the sequence of events in apoptosis induced by TGFβ1 in an EBV negative, human B-cell lymphoma line (HT58). The proportion of apoptotic cells increased gradually (up to 72 hr) at an optimal dose range of 0.5-1.0 ng/ml. The induced cell death required the action of downstream caspases. Caspase activation was accompanied by an increase in the permeability of mitochondrial membranes, but there was no change in the expression of certain members of Bcl-2 family (Bcl-2, Bax, Bcl-XL). Similarly, none of the death receptors or ligands were involved in apoptosis induction. Further study will include the participation of TGFβ1 target genes in the pore formation of mitochondrial membranes and/or the elimination ora putative survival signal.",
keywords = "Apoptosis, Caspases, Death receptors, Lymphoma, Mitochondria, TGFβ1",
author = "A. T{\'o}tth and A. Sebesty{\'e}n and G. Barna and K. Nagy and A. G{\"o}nd{\"o}r and J. Bocsi and R. Mihalik and I. Pet{\'a}k and J. Houghton and L. K{\'o}pper",
year = "2001",
language = "English",
volume = "21",
pages = "1207--1212",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 A",

}

TY - JOUR

T1 - TGFβ1 induces caspase-dependent but death-receptor independent apoptosis in lymphoid cells

AU - Tótth, A.

AU - Sebestyén, A.

AU - Barna, G.

AU - Nagy, K.

AU - Göndör, A.

AU - Bocsi, J.

AU - Mihalik, R.

AU - Peták, I.

AU - Houghton, J.

AU - Kópper, L.

PY - 2001

Y1 - 2001

N2 - Transforming growth factor beta 1 (TGFβ1) is an antiproliferative and proapoptotic cytokine for normal B-cells, however many B-cell lymphomas have lost their response to TGFβ1. The aim of this study was to identify the sequence of events in apoptosis induced by TGFβ1 in an EBV negative, human B-cell lymphoma line (HT58). The proportion of apoptotic cells increased gradually (up to 72 hr) at an optimal dose range of 0.5-1.0 ng/ml. The induced cell death required the action of downstream caspases. Caspase activation was accompanied by an increase in the permeability of mitochondrial membranes, but there was no change in the expression of certain members of Bcl-2 family (Bcl-2, Bax, Bcl-XL). Similarly, none of the death receptors or ligands were involved in apoptosis induction. Further study will include the participation of TGFβ1 target genes in the pore formation of mitochondrial membranes and/or the elimination ora putative survival signal.

AB - Transforming growth factor beta 1 (TGFβ1) is an antiproliferative and proapoptotic cytokine for normal B-cells, however many B-cell lymphomas have lost their response to TGFβ1. The aim of this study was to identify the sequence of events in apoptosis induced by TGFβ1 in an EBV negative, human B-cell lymphoma line (HT58). The proportion of apoptotic cells increased gradually (up to 72 hr) at an optimal dose range of 0.5-1.0 ng/ml. The induced cell death required the action of downstream caspases. Caspase activation was accompanied by an increase in the permeability of mitochondrial membranes, but there was no change in the expression of certain members of Bcl-2 family (Bcl-2, Bax, Bcl-XL). Similarly, none of the death receptors or ligands were involved in apoptosis induction. Further study will include the participation of TGFβ1 target genes in the pore formation of mitochondrial membranes and/or the elimination ora putative survival signal.

KW - Apoptosis

KW - Caspases

KW - Death receptors

KW - Lymphoma

KW - Mitochondria

KW - TGFβ1

UR - http://www.scopus.com/inward/record.url?scp=0035002231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035002231&partnerID=8YFLogxK

M3 - Article

C2 - 11396165

AN - SCOPUS:0035002231

VL - 21

SP - 1207

EP - 1212

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 A

ER -